Alkermes Plc (ALKS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Alkermes Plc   (NASDAQ: ALKS)
 

Alkermes Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Alkermes Plc inventory turnover ratio, the Alkermes Plc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.01 in the second quarter 2026, yet the ratio remained below the average, as ALKS's market remain challenging.Average inventory processing period, for the Alkermes Plc in Jun 30 2026 quarter, has decreased to 361 days, compare to 401 days, in the Mar 31 2026 quarter.

Within Healthcare sector 312 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1142 in the first quarter 2026, to 1821.

ALKS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alkermes Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALKS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 55.77 % 83.55 % 7.51 % -0.05 % -1.44 %
Y / Y Cost of Sales Growth 98.37 % 25.17 % -25.61 % -18.24 % -19.54 %
Inventory Turnover Ratio (TTM) 1.01 0.91 1.03 1.13 1.2
ALKS's Total Ranking # 1821 # 1142 # 1288 # 1131 # 1393
Average inventory processing period 363 400 354 322 305
Seq. Inventory Growth -11.21 % 71.24 % 2.95 % -0.48 % 4.63 %
Seq. Cost of Sales Growth 59.33 % 33.26 % -10.43 % 4.31 % 0.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 92
Healthcare Sector # 313
Overall Market # 1821

Inventory Turnover Ratio Statistics
High Average Low
4.37 2.16 0.91
(Sep 30 2013)   (Mar 31 2026)



ALKS Company Profile >> Back to ALKS Efficiency Comparisons >> Compare ALKS Inventory Turnover Ratio to its Competitors

Financial Statements
Alkermes Plc 's Inventories $ 299 Millions Visit ALKS's Balance sheet
Alkermes Plc 's Cost of Revenues TTM $ 257 Millions Visit ALKS's Income Statement
What are ALKS's Sales? Visit ALKS's Sales by Segment

Other Inventory Turnover Ratios
Alkermes Plc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ALKS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ALKS's Competitors
Inventory Turnover Ratio for ALKS's Suppliers
Inventory Turnover Ratio for ALKS's Customers

You may also want to know
ALKS's Sales Growth Rates ALKS's Pe Price to earnings ratio ALKS's Receivables Turnover Ratio ALKS's Stock Quote
ALKS's Net Income Growth Rates ALKS's Ps Price to Sales ratio ALKS's Sales per Employee ALKS's Asset Turnover Ratio
ALKS's Net Margin ALKS's Pb Price to Book ratio ALKS's Financial Strength Ratios ALKS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Aurinia Pharmaceuticals Inc   2.34 $ 30.036  Millions$ 13  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Resmed Inc   2.33 $ 2,176.428  Millions$ 933  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
Merit Medical Systems Inc  2.30 $ 798.467  Millions$ 347  Millions
Tela Bio Inc   2.30 $ 26.348  Millions$ 11  Millions
Sanara Medtech Inc   2.29 $ 7.981  Millions$ 3  Millions
China Pharma Holdings Inc  2.25 $ 3.450  Millions$ 2  Millions
Beta Bionics Inc   2.23 $ 50.111  Millions$ 22  Millions
Apyx Medical Corp  2.21 $ 21.014  Millions$ 10  Millions
Medtronic Plc  2.21 $ 13,136.000  Millions$ 5,950  Millions
Caredx Inc   2.20 $ 48.623  Millions$ 22  Millions
Embecta Corp   2.19 $ 418.400  Millions$ 191  Millions
Avita Medical Inc   2.18 $ 13.950  Millions$ 6  Millions
Johnson and Johnson  2.17 $ 31,428.000  Millions$ 14,516  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.15 $ 14.508  Millions$ 7  Millions
Orthofix Medical Inc   2.15 $ 240.218  Millions$ 112  Millions
Icu Medical Inc  2.15 $ 1,314.853  Millions$ 613  Millions
Anika Therapeutics Inc   2.14 $ 46.366  Millions$ 22  Millions
Amphastar Pharmaceuticals Inc   2.14 $ 381.911  Millions$ 178  Millions
Bioventus Inc   2.14 $ 182.542  Millions$ 85  Millions
Dariohealth Corp   2.10 $ 8.985  Millions$ 4  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Aytu Biopharma Inc  2.09 $ 18.697  Millions$ 9  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Anteris Technologies Global Corp   2.08 $ 0.561  Millions$ 0  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Boston Scientific Corporation  2.07 $ 6,315.000  Millions$ 3,054  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.